Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.
about
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDTBeyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic TherapyIdentification of ovarian cancer metastatic miRNAsHigh-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional modelsFlow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platformIn vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform.Longitudinal, quantitative monitoring of therapeutic response in 3D in vitro tumor models with OCT for high-content therapeutic screening.Two combined photosensitizers: a goal for more effective photodynamic therapy of cancerMethylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells.Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor modelsUse of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes.A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFRLongitudinal measurement of extracellular matrix rigidity in 3D tumor models using particle-tracking microrheology.Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Photobleaching and phototoxicity of KillerRed in tumor spheroids induced by continuous wave and pulsed laser illumination.Digital holographic microscopy for longitudinal volumetric imaging of growth and treatment response in three-dimensional tumor models.A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput formatOptimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.The role of photodynamic therapy in overcoming cancer drug resistance.Quantitative imaging of light-triggered doxorubicin release.Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy.Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT ParametersSimultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence TomographyStromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways.Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.Longitudinal, label-free, quantitative tracking of cell death and viability in a 3D tumor model with OCT.PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour modelsSynergism between airborne singlet oxygen and a trisubstituted olefin sulfonate for the inactivation of bacteria.High-resolution deep imaging of live cellular spheroids with light-sheet-based fluorescence microscopy.Bottom-Up Engineering of Well-Defined 3D Microtissues Using Microplatforms and Biomedical Applications.Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma.
P2860
Q27324380-04D62C0B-48C2-413B-A14C-EF03BFF78184Q28079955-B23CD675-7806-4B58-9D9D-1D98AE397C88Q28487932-1CCE3A37-11D4-4A02-8F38-CEAE2D9F943CQ28834438-6E627CBE-EB1E-41EE-B314-2F3899882EDFQ30446755-D1CE0345-F128-43EE-A442-8E901443FC3FQ30449030-22E6F04D-6F08-4359-8719-CB08D2B445B6Q30531713-7511B90C-4369-4BA7-A2B4-51B031E8921AQ30573238-3BFEA1BD-5462-40F3-AB09-347EB680C50FQ30575303-69612FB7-CD88-445D-8B26-AA9F86674512Q30842073-982B1AE9-6C1A-4A2F-B86F-A176054B985EQ33443634-889DCCA5-C160-4EF1-8B82-0FBEAD7A7317Q33713297-A7A5D781-456B-4138-A112-D532E76B5B8BQ33835932-8231D0C4-624C-40A8-9C07-B836AA77D944Q33872423-8AE35F31-DFF3-4C8F-A085-49B1C29B0087Q34068126-FAD098C0-09FE-4408-8A52-ECBB9086D73FQ35165488-0BCA5FE7-4CD3-4969-9B15-4CAB2DECB0A4Q35554620-A3D76F35-EA93-45AA-B244-3E733F35EC60Q35717332-21263EC1-E11C-4A44-A112-DA59C8CD643EQ35817502-BE3FD970-CDDD-4079-AD22-960A1E258AC3Q35837949-91B4AEF8-3F36-4B3D-B1EB-C930256A3320Q35904547-934DC543-3130-4E05-B6D4-CFBAE07F2CBAQ36072171-4FB44957-319C-4DC8-8050-CD2C0408A9FBQ36088759-27DAC5E5-9B69-4243-8705-8CD28D83EF86Q36329641-9F402062-05A7-49D3-BF57-5B038489B929Q36505652-A6AF493F-B228-4250-BCB4-DE679C71C0D6Q36513863-0DC7AFBD-7FE1-4F76-8A93-D047DEB1BF17Q36641872-D9148B8B-1EE8-44AD-83DD-A38D189EA843Q36767541-937EC6D3-E895-45E2-89E0-F1D094B14F65Q36790826-45F704C9-27CC-428D-AD30-83C99D208E58Q36955529-D1B26C16-762D-4496-A327-CBA48ECF5B53Q36983114-3409FF60-9702-4626-B7CE-B2306CEC5E8FQ37115994-6151ECB5-B50B-47FF-8F11-9D707B7F3C0AQ37197458-44D1DBF4-E09C-4379-93ED-8F27D114968DQ37489267-F891D4FA-EE66-47A7-98B7-8CAD59DE6F63Q37714182-AB12149E-6912-48D8-89F6-C165D7D691C8Q38084845-3E21D436-D04E-4B5B-B255-0B01F2FC4934Q38424004-89C00F48-03C7-4B64-BD41-C2B8F432AF1CQ38446206-D2894AA0-D947-4AC1-93FE-AA9700AE0E36Q38722983-E4EF9EC3-D912-4579-AF0B-12A70CF4355FQ38743588-14C1A2CF-E5B1-4499-8E45-A884F397C945
P2860
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@ast
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@en
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@nl
type
label
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@ast
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@en
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@nl
prefLabel
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@ast
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@en
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@nl
P2093
P2860
P50
P1433
P1476
Synergistic enhancement of car ...... icrometastatic ovarian cancer.
@en
P2093
Adnan O Abu-Yousif
Alona Muzikansky
Conor L Evans
Dianne Finkelstein
Jonathan P Celli
Tayyaba Hasan
P2860
P304
P356
10.1158/0008-5472.CAN-10-1783
P407
P577
2010-11-09T00:00:00Z